Health

FDA will review safety of testosterone therapy

(HealthDay)—Spurred by a recent report that popular testosterone treatments might raise men's heart risk, the U.S. Food and Drug Administration says it now plans a review of the therapies' safety.

Cardiology

Testosterone therapy might increase heart attack risk

(HealthDay)—Testosterone therapy—widely advertised as a way to help men improve a low sex drive and reclaim diminished energy—might raise the risk of heart attack, according to new research.

Medical research

Testosterone gel fails to boost Viagra's effects

(HealthDay)—Men who have erectile dysfunction and low testosterone may get no extra benefit from adding the hormone to their Viagra prescription, a new study suggests.

Medications

Tefina, a 'female Viagra', currently being studied

Tefina, the first testosterone based intranasal gel, has been in part developed by the ULg's Galenic Pharmacy Laboratory. It is currently at the stage of testing before being marketed by the Canadian company, Trimel Pharmaceuticals.

page 2 from 2